Improving the Quality of Life in the Most Delicate Patient Group: Preterm Infants

Premature birth is the number one cause of infant mortality in the United States. Improving the quality of life matters, especially from the moment the most delicate patient is born. Today’s guest is Dr. Amir Fassihi, CEO and founder of Amnion Life. He has been spearheading the company's efforts in developing AmnioBed, a True Quality medical device that aims to save the lives of thousands preterm babies born every year and. Some of the highlights of the show include: - Any minor insult or trauma from the environment that a baby born early suffers from could have devastatingly decades-long consequences to the human body. - To help prevent complications, Amir dreamt that preemies should be in synthetic amniotic fluid called, Amnion. He started Amnion Life to turn a dream into reality. - Due to the cost and complexity of developing the AmnioBed medical device, Amnion Life selected to work on it with qualified Serbian engineers. - In 2019, Amnion Life plans to do testing and verification of AmnioBed. In 2020, it will begin conducting clinical trials. - Amir hasn’t faced typical issues that founders of startups experience. He doesn’t need to take salary from the company, works remotely, and has flexible hours. - Why didn’t anybody develop such a medical device sooner? Proper guidelines and standards didn’t exist years ago to know how to build a safe device. - Amnion Life creates the same content of a womb’s amniotic fluid, but purifies it by filtering out toxins and other substances to become dialysis-grade water. - Be patient and take things in stride. Startup founders/CEOs don’t need to be an expert on everything; surround yourself with the right people.